Jiangsu Hengrui Medicine Co., Ltd. (SHA:600276)
China · Delayed Price · Currency is CNY 71.09
-1.22 (-1.69%)
Sep 9, 2025, 3:00 PM CST
Jiangsu Hengrui Medicine Market Cap
Jiangsu Hengrui Medicine has a market cap or net worth of 481.32 billion as of September 8, 2025. Its market cap has increased by 73.50% in one year.
Market Cap
481.32B
Enterprise Value
445.74B
Revenue
30.15B
Ranking
n/a
PE Ratio
62.31
Stock Price
71.09
Market Cap Chart
Since October 20, 2000, Jiangsu Hengrui Medicine's market cap has increased from 2.58B to 481.32B, an increase of 18,580.54%. That is a compound annual growth rate of 23.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 481.32B | 64.91% |
| Dec 31, 2024 | 291.86B | 1.48% |
| Dec 29, 2023 | 287.60B | 17.03% |
| Dec 30, 2022 | 245.74B | -23.94% |
| Dec 31, 2021 | 323.08B | -45.40% |
| Dec 31, 2020 | 591.75B | 53.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| WuXi AppTec | 322.73B |
| Shenzhen Mindray Bio-Medical Electronics | 299.98B |
| Sichuan Biokin Pharmaceutical | 155.60B |
| Zhangzhou Pientzehuang Pharmaceutical., | 124.16B |
| Aier Eye Hospital Group | 120.10B |
| Shanghai United Imaging Healthcare | 116.97B |
| Yunnan Baiyao Group Co.,Ltd | 105.81B |
| Huadong Medicine | 76.35B |